Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MALT1 | Q9UDY8 | 5/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.38 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.38 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.38 |
| ▸ | RBP4 | P02753 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30206595 | 0.91 | MALT1 (0.38) | MALT1SLC16A3SLC16A1RBP4NPC1 | |
| SCHEMBL340847 | 0.91 | MALT1 (0.38) | MALT1SLC16A3SLC16A1RBP4NPC1 | |
| SCHEMBL421559 | 0.91 | MALT1 (0.38) | MALT1SLC16A3SLC16A1RBP4NPC1 | |
| SCHEMBL341689 | 0.89 | DHODH (0.38) | MALT1SLC16A3SLC16A1RBP4NPC1 | |
| SCHEMBL30234226 | 0.89 | ALDH1A1 (0.47) | NPC1RAB9AALDH1A1KMT2APOLB | |
| SCHEMBL25008752 | 0.89 | SLC16A3 (0.41) | MALT1SLC16A3SLC16A1RBP4ALDH1A1 | |
| SCHEMBL16014672 | 0.89 | MALT1 (0.37) | MALT1SLC16A3SLC16A1RBP4NPC1 | |
| SCHEMBL29215224 | 0.89 | ALDH1A1 (0.47) | NPC1RAB9AALDH1A1KMT2APOLB | |
| SCHEMBL10118188 | 0.89 | NAMPT (0.39) | MALT1NAMPTOPRL1SLC16A3SLC16A1 | |
| SCHEMBL28802119 | 0.88 | ALDH1A1 (0.38) | MALT1SLC16A3SLC16A1RBP4NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9056861-B2 | Process for preparing tetrazole-substituted anthranilamide derivatives and novel crystal polymorphs of these derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-06-16 | — | — | US | disclosed |
| US-8969572-B2 | Process for preparing tetrazole-substituted anthranilamide derivatives and novel crystal polymorphs of these derivatives | BAYER CROPSCIENCE AG (DE) | 2015-03-03 | — | — | US | disclosed |
| US-20150025116-A1 | PROCESS FOR PREPARING TETRAZOLE-SUBSTITUTED ANTHRANILAMIDE DERIVATIVES AND NOVEL CRYSTAL POLYMORPHS OF THESE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2015-01-22 | — | — | US | disclosed |
| US-20120101133-A1 | PROCESS FOR PREPARING TETRAZOLE-SUBSTITUTED ANTHRANILAMIDE DERIVATIVES AND NOVEL CRYSTAL POLYMORPHS OF THESE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150025116-A1 | PROCESS FOR PREPARING TETRAZOLE-SUBSTITUTED ANTHRANILAMIDE DERIVATIVES AND NOVEL CRYSTAL POLYMORPHS OF THESE DERIVATIVES | CYP4F3, CYP4F12, CYP3A5 | MALT1 2320/4885NAMPT 775/4885OPRL1 4808/4885 |
| US-20120101133-A1 | PROCESS FOR PREPARING TETRAZOLE-SUBSTITUTED ANTHRANILAMIDE DERIVATIVES AND NOVEL CRYSTAL POLYMORPHS OF THESE DERIVATIVES | CYP4F3, CYP4F12, CYP3A5 | MALT1 2320/4885NAMPT 775/4885OPRL1 4808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.